Friday September 18, 2020 22:56

Heathcare Press Release : 07 Aug 2020

How Protein Can Help You Resist Unhealthy Holiday Temptations Heathcare—07 Aug 20

By: Susan Bowerman, M.S.,RD,CSSD, CSOWM, FAND – Sr.Director, Worldwide Nutrition Education and Training, Herbalife Nutrition The holidays are a time to be around friends, family,and of course, food. But many of our holiday treats and dishes can

Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development Heathcare—07 Aug 20

MONTREAL and ROTTERDAM Netherlands--7 Aug--PRNewswire/InfoQuest

Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to announce a new partnership that will offer global, integrated services to support discovery and development of vaccines and antiviral therapies.

Caprion-HistoGeneX and Viroclinics-DDL announced today a new strategic partnership to expand their global capabilities addressing the emerging needs for therapeutic and prophylactic solutions to target infectious diseases including COVID-19. This partnership brings together the leadership of two prominent contract research organizations serving the pharmaceutical and biotechnology community with specialized assays and technologies relevant to clinical and preclinical studies aimed at developing vaccines and other therapies for infectious diseases.

By combining their respective expertise, the two companies offer a full suite of specialized services to support vaccine and antiviral studies along with a broad global presence, including sites in The Netherlands, Canada, USA, Belgium, UK, Australia, and China.

"We are excited to partner with Caprion-HistoGeneX and combine the unique strengths of our companies